Ivacaftor

Nat Rev Drug Discov. 2012 Apr 30;11(5):349-50. doi: 10.1038/nrd3723.
No abstract available

Publication types

  • News

MeSH terms

  • Aminophenols / adverse effects
  • Aminophenols / pharmacology
  • Aminophenols / therapeutic use*
  • Cystic Fibrosis / drug therapy*
  • Cystic Fibrosis / genetics
  • Cystic Fibrosis / physiopathology
  • Cystic Fibrosis Transmembrane Conductance Regulator / genetics
  • Drug Approval
  • Humans
  • Mutation / genetics*
  • Quinolones / adverse effects
  • Quinolones / pharmacology
  • Quinolones / therapeutic use*
  • United States
  • United States Food and Drug Administration

Substances

  • Aminophenols
  • CFTR protein, human
  • Quinolones
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • ivacaftor